BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

595 related articles for article (PubMed ID: 27977138)

  • 1. Drugging the Undruggable: Therapeutic Potential of Targeting Protein Tyrosine Phosphatases.
    Zhang ZY
    Acc Chem Res; 2017 Jan; 50(1):122-129. PubMed ID: 27977138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bidentate inhibitors of protein tyrosine phosphatases.
    Low JL; Chai CL; Yao SQ
    Antioxid Redox Signal; 2014 May; 20(14):2225-50. PubMed ID: 24206395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bicyclic benzofuran and indole-based salicylic acids as protein tyrosine phosphatase inhibitors.
    He Y; Zeng LF; Yu ZH; He R; Liu S; Zhang ZY
    Bioorg Med Chem; 2012 Mar; 20(6):1940-6. PubMed ID: 22133902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug discovery and protein tyrosine phosphatases.
    Blaskovich MA
    Curr Med Chem; 2009; 16(17):2095-176. PubMed ID: 19519384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein-tyrosine phosphatases: structure, mechanism, and inhibitor discovery.
    Burke TR; Zhang ZY
    Biopolymers; 1998; 47(3):225-41. PubMed ID: 9817026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probing the molecular basis for potent and selective protein-tyrosine phosphatase 1B inhibition.
    Guo XL; Shen K; Wang F; Lawrence DS; Zhang ZY
    J Biol Chem; 2002 Oct; 277(43):41014-22. PubMed ID: 12193602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein tyrosine phosphatase inhibition by metals and metal complexes.
    Lu L; Zhu M
    Antioxid Redox Signal; 2014 May; 20(14):2210-24. PubMed ID: 24382261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Tyrosine Phosphatases: Time to End the Stigma.
    Stanford SM; Bottini N
    Trends Pharmacol Sci; 2017 Jun; 38(6):524-540. PubMed ID: 28412041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional interrogation and therapeutic targeting of protein tyrosine phosphatases.
    Krabill AD; Zhang ZY
    Biochem Soc Trans; 2021 Aug; 49(4):1723-1734. PubMed ID: 34431504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allele-specific inhibitors of protein tyrosine phosphatases.
    Hoffman HE; Blair ER; Johndrow JE; Bishop AC
    J Am Chem Soc; 2005 Mar; 127(9):2824-5. PubMed ID: 15740097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of inhibitor-sensitive protein tyrosine phosphatases via active-site mutations.
    Bishop AC; Zhang XY; Lone AM
    Methods; 2007 Jul; 42(3):278-88. PubMed ID: 17532515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in the development of allosteric protein tyrosine phosphatase inhibitors for drug discovery.
    Elhassan RM; Hou X; Fang H
    Med Res Rev; 2022 May; 42(3):1064-1110. PubMed ID: 34791703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional studies of protein tyrosine phosphatases with chemical approaches.
    Zhang ZY
    Biochim Biophys Acta; 2005 Dec; 1754(1-2):100-7. PubMed ID: 16226063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metal-based inhibitors of protein tyrosine phosphatases.
    Lu L; Zhu M
    Anticancer Agents Med Chem; 2011 Jan; 11(1):164-71. PubMed ID: 21269257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting SHP-1, 2 and SHIP Pathways: A Novel Strategy for Cancer Treatment?
    Dempke WCM; Uciechowski P; Fenchel K; Chevassut T
    Oncology; 2018; 95(5):257-269. PubMed ID: 29925063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Covalent inhibition of protein tyrosine phosphatases.
    Ruddraraju KV; Zhang ZY
    Mol Biosyst; 2017 Jun; 13(7):1257-1279. PubMed ID: 28534914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical and mechanistic approaches to the study of protein tyrosine phosphatases.
    Zhang ZY
    Acc Chem Res; 2003 Jun; 36(6):385-92. PubMed ID: 12809524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein tyrosine phosphatases: structure and function, substrate specificity, and inhibitor development.
    Zhang ZY
    Annu Rev Pharmacol Toxicol; 2002; 42():209-34. PubMed ID: 11807171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxyindole carboxylic acid-based inhibitors for receptor-type protein tyrosine protein phosphatase beta.
    Zeng LF; Zhang RY; Bai Y; Wu L; Gunawan AM; Zhang ZY
    Antioxid Redox Signal; 2014 May; 20(14):2130-40. PubMed ID: 24180557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic approaches to studying protein tyrosine phosphatases.
    Liang F; Kumar S; Zhang ZY
    Mol Biosyst; 2007 May; 3(5):308-16. PubMed ID: 17460790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.